ZEE Entertainment shares rally 5% after Q4 results. Should you buy, sell or hold?

ZEEL swung back to profit in March quarter against loss a year ago. Its total income in the reporting quarter, too, increased 3% YoY to Rs 2,185 core. Goldman Sachs sees partial recovery in revenues as a positive sign.

Shares of rose 5% on Saturday on BSE to the day’s high of Rs 141.65 after the company on Friday reported a for the March against loss a year ago.

Zee on Friday reported a net profit of Rs 13.35 crore for the quarter ended March 2024, compared with a loss of Rs 196 crore in the same quarter of last year. The total income in the reporting quarter increased 3% year-on-year to Rs 2,185 core.

ZEE has said that it will see most of the one-time higher costs towards implementing the interventions in the current quarter, offsetting underlying operating performance improvements and causing softness on margins.

Also read:

Here’s how view the results:

Goldman Sachs


The partial recovery in revenues was appreciable. However, margins remained subdued coupled with a weak EBITDA profile at 9.7% for the fourth quarter. Goldman has cut its fY25-27 revenue/EBITDA estimate forecasts by 5%-8%/30%-37%.

The global brokerage has a ‘neutral’ view on the stock with cut down to Rs 167.

Nuvama


Zee Entertainment posted Q4FY24 revenue/EBITDA (up 2.7%/38.5% YoY) beating Nuvama’s estimates. Overall, the brokerage increased FY25E/26E forecast by 1.4%/2.6% on the back of improving outlook for FMCG advertisers, but cut EPS by 19%/6% as ZEE is transitioning towards a more focused structure, entailing high one-time costs in FY25.

has upgraded the stock to ‘buy’ from an earlier ‘reduce’ with a revised target of Rs 180.

Emkay Global


Domestic brokerage firm Emkay Global said it is building in some recovery on the front for ZEE (7% growth in FY25E/26E) aided by a lower base and persistent recovery in overall ad spending. Subscription revenues should see an uptick due to price hikes. Margins should also improve on account of multiple interventions, though Emkay reiterated that a significant re-rating should happen in case of a new buyer/partner. Any unfavorable decision in legal cases the company is involved in could be a key risk.

Emkay has maintained a ‘reduce’ rating on the stock with an unchanged target price of Rs 150.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?